ZIMV Stock Recent News

Net Sales from Continuing Operations of $112.0 million Net Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA [ 1] from Continuing Operations of $17.6 million; Adjusted EBITDA [1] margin of 15.7% GAAP diluted EPS from Continuing Operations of $(0.09) and adjusted diluted EPS [1] from Continuing Operations of $0.27 PALM BEACH GARDENS, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter ended March 31, 2025.

PALM BEACH GARDENS, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2025 after market close on Thursday, May 8, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

PALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in the United States.

PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.

PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including:

Dentsply Sirona  XRAY and ZimVie Inc. ZIMV show below-market growth and have no meaningful upside, according Needham analysts.

ZimVie Inc. (NASDAQ:ZIMV ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Vafa Jamali - President & Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS William McMahon - Barclays Operator Good afternoon and welcome to ZimVie's Fourth Quarter 2024 Earnings Conference Call. Currently, all participants are in a listen-only mode.

PALM BEACH GARDENS, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financial results for the quarter and year ended December 31, 2024. Management will host a corresponding conference call today, February 26, 2025, at 4:30 p.m. Eastern Time.

PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health